Skip to main content

Prof. Dr. Dr. Pierluigi Nicotera

Member

German Center for Neurodegenerative Diseases (DZNE)

Venusberg-Campus 1/99, 53127 Bonn

office-nicotera@dzne.de

+49 228 43302602

Website

Prof. Nicotera’s main research focus is on molecular mechanisms of cell death and neurodegeneration.

Pierluigi Nicotera

Download biosketch

Recent publications

  • Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol.

    Pain management

    Authors: Damiana Scuteri, Gary W Lawrence, Rosario Iannacchero, Michele Trimboli, Pierluigi Nicotera, Maria T Corasaniti, Giacinto Bagetta

  • Mitochondrial complex I inhibition enhances astrocyte responsiveness to pro-inflammatory stimuli.

    Scientific reports

    Authors: Lena Wischhof, Amal John Mathew, Lorenzo Bonaguro, Marc Beyer, Dan Ehninger, Pierluigi Nicotera, Daniele Bano

  • Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)-Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National …

    Pharmaceutics

    Authors: Damiana Scuteri, Daniele Pierobon, Martina Pagliaro, Kengo Hamamura, Takafumi Hayashi, Loris Pignolo, Pierluigi Nicotera, Giacinto Bagetta, Maria Tiziana Corasaniti

All publications by Prof. Dr. Dr. Pierluigi Nicotera